How active is Private Equity / PE-Backed Roll-Up in medical devices acquisitions?

49 disclosed private equity / pe-backed roll-up acquisitions of medical devices businesses analyzed (49 from 2018+). Run the ExitValue.ai calculator to see what this buyer pool would pay for your specific business.

Who are the most active private equity / pe-backed roll-up buyers of medical devices businesses?

Top recent acquirers by deal count: Altaris, LLC (2 deals), Altaris Capital Partners (2 deals), Agilent Technologies, Inc. (1 deals), Boston Scientific Corporation (1 deals), Kingswood Capital Management, LP (1 deals), Forager Capital Management LLC (1 deals).

BUYER POOL ANALYSIS

Selling a Medical Devices to Private Equity / PE-Backed Roll-Up buyers

Private equity firms and PE-backed platform consolidators acquiring for roll-up, add-on, or platform plays. Pricing tends to lead the market for fee-viable scale, with multi-bidder competitive processes above the EBITDA floor.

Quick answers

How many disclosed transactions?: 49 deals total (49 from 2018+), filtered to Private Equity / PE-Backed Roll-Up acquirers of medical devices businesses.
Most active buyers: Altaris, LLC (2) · Altaris Capital Partners (2) · Agilent Technologies, Inc. (1) · Boston Scientific Corporation (1) · Kingswood Capital Management, LP (1) · Forager Capital Management LLC (1)
What would this buyer pool pay for my business?: Run the ExitValue.ai calculator to see your medical devices priced against the 49 disclosed private equity / pe-backed roll-up transactions in this segment. The engine surfaces the specific multiples that apply to your size, margin, and growth profile.

Recent disclosed deals

Private Equity / PE-Backed Roll-Up acquisitions of medical devices businesses with named target and named acquirer.

Year	Target	Acquirer
2026	Biocare Medical, LLC	Agilent Technologies, Inc.
2026	Penumbra, Inc.	Boston Scientific Corporation
2025	Quipt Home Medical Corp.	Kingswood Capital Management, LP
2025	Quipt Home Medical Corp.	Forager Capital Management LLC
2025	Xtant Medical Holdings, Inc.	Corbin Capital Partners, L.P.
2025	Hologic, Inc.	Blackstone / TPG

What this buyer pool prices for

Private equity acquirers price for scale and roll-up arbitrage. They pay up for businesses that fit a platform thesis - recurring revenue mix above 30%, technician/professional depth, clean financials, and a management layer that survives integration. A medical devices that fits the platform thesis prices materially above what an individual buyer would pay because PE is buying a platform piece, not an owner-operated shop.

Methodology note

Deal flow shown reflects disclosed M&A transactions in the ExitValue.ai database, filtered to medical devices businesses acquired by private equity / pe-backed roll-up buyers. Deal counts shown reflect deals with disclosed financials only - total transaction count for this buyer pool is typically 2-3x larger. The valuation engine reveals the specific multiples that apply to your business when you run the calculator above. Full methodology

What's your medical devices worth to private equity / pe-backed roll-up?

12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.

✓Sellability score with 5-driver breakdown and lift estimates
✓Named comparable M&A transactions in your sub-vertical
✓AI-written analysis grounded in your specific inputs

Run my valuation analysis →

Engine-grounded estimate. Comparable private equity / pe-backed roll-up deals on the full results page.